Business
Circular and Notice of General Meeting
Circular and Notice of General Meeting.
About this update from Agronomics Limited
[{"type":"text","content":"\n \nRNS Number : 3967U Port Erin Biopharma Investments Ltd 29 March 2019 \n\n7.00am 29 March 2019\n \nPort Erin Biopharma Investments Limited\n(the \"Company\")\n \nCircular and Notice of General Meeting\n \nThe Company is pleased to announce that it has today posted a Circular to Shareholders seeking approval for a change of its Investing Policy and a name change to Agronomics Limited. The General Meeting (\"GM\") will be held at the Claremont Hotel, Loch Promenade, Douglas, Isle of Man IM1 2LX, at 11:00 a.m. on 16 April 2019. A copy of the Circular is being posted to Shareholders and is available on the Company's website, https://www.porterinbiopharma.com.\n \nThe proposed new Investing Policy is as follows:\n \n \n''The Company will invest in opportunities within the Life Sciences sector, concentrating on, but not being limited to, environmentally friendly alternatives to the traditional production of meat and plant-based nutrition sources (\"Clean Food\"). The Company will focus on investments that provide scalable and commercially viable opportunities.\nThe Company will invest in equity and equity related products in both quoted companies, which offer the benefits of liquidity, and in unquoted companies which offer the attraction of additional capital gains upon completion of a successful IPO. The Company may also invest in shares of collective investment schemes with exposure to the Life Science sector and in long-term equity anticipation securities the underlying securities of which will be based on Life Science sector securities and/or indices relating to the Life Science sector. The Fund may invest in Life Science Sector debt. Investments in Life Science sector debt shall not exceed 15 per cent. of the Net Asset Value of the Company.\nThe Company will be ungeared. The Company will be a passive investor.\nThe Company aims to deliver capital growth by realising capital gains when it considers that the valuation of individual investments looks to be excessive or, as is often the case in this sector, as a result of trade sales.\nAssets and investments will be held by the Company directly or through the individual share custodians of the brokers used by the Company to acquire the shares.\nAny material variation to the Investing Policy will require the approval of Shareholders at a general...